BML264 ((E)-N-(p-amylcinnamoyl) anthranilic acid) is an agonist for TREK-1 . BML264 can be used to study diseases associated with TASK1 dysfunction.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Potassium Channel
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。